Oncolytics Biotech Inc ONCY

Primary Symbol: T.ONC

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > A takeover now would be great

<< Previous

Bullboard Posts

Next >>

Comment by inthnoon Mar 17, 2023 11:58am

137 Views

Post# 35345156

RE:A takeover now would be great

I guess you are trying to see who will bite on a post like this. Let's see, so you are saying let's sell the company for half of what it was trading at around the consolidation price and when we had no panc, aware1 or Bracelet and no one can resist. Wow you are a genius to come up with such a novel idea and price.

<< Previous

Bullboard Posts

Next >>

A PGM mining stock with value written all over it